| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.38 | 0.03 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | 0.35 | 0.03 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.36 | 0.03 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.37 | 0.03 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.27 | 0.03 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.077 | 0.03 |